{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T09:52:35Z","timestamp":1756461155897,"version":"3.35.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T00:00:00Z","timestamp":1574121600000},"content-version":"vor","delay-in-days":18,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.heliyon.2019.e02890","type":"journal-article","created":{"date-parts":[[2019,11,26]],"date-time":"2019-11-26T07:26:03Z","timestamp":1574753163000},"page":"e02890","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Expression of serotonin 2A, 2C, 6 and 7 receptor and IL-6 mRNA in experimental toxoplasmic encephalitis in mice"],"prefix":"10.1016","volume":"5","author":[{"given":"Hasan Tarik","family":"Atmaca","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.heliyon.2019.e02890_bib1","first-page":"1","article-title":"Latent toxoplasmosis and human, Iran","volume":"7","author":"Dalimi","year":"2012","journal-title":"J.\u00a0Parasitol."},{"issue":"2","key":"10.1016\/j.heliyon.2019.e02890_bib2","doi-asserted-by":"crossref","first-page":"105","DOI":"10.14411\/fp.2010.013","article-title":"Toxoplasmosis as a cause for behaviour disorders - overview of evidence and mechanisms","volume":"57","author":"Fekadu","year":"2010","journal-title":"Folia Parasitol."},{"issue":"7","key":"10.1016\/j.heliyon.2019.e02890_bib3","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/NMD.0b013e318221416e","article-title":"Toxoplasma gondii seropositivity and suicide rates in women","volume":"199","author":"Ling","year":"2011","journal-title":"J.\u00a0Nerv. Ment. Dis."},{"issue":"1","key":"10.1016\/j.heliyon.2019.e02890_bib4","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1242\/jeb.073635","article-title":"Influence of latent Toxoplasma infection on human personality, physiology and morphology: pros and cons of the Toxoplasma-human model in studying the manipulation hypothesis","volume":"216","author":"Flegr","year":"2013","journal-title":"J.\u00a0Exp. Biol."},{"issue":"4","key":"10.1016\/j.heliyon.2019.e02890_bib5","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.pt.2013.01.007","article-title":"How and why Toxoplasma makes us crazy","volume":"29","author":"Flegr","year":"2013","journal-title":"Trends Parasitol."},{"issue":"4","key":"10.1016\/j.heliyon.2019.e02890_bib6","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1176\/appi.neuropsych.12100234","article-title":"Windows to the brain: latent toxoplasmosis gondii: emerging evidence for influences on neuropsychiatric disorders","volume":"24","author":"a Hurley","year":"2012","journal-title":"J.\u00a0Neuropsychiatr. Clon. Neurosci."},{"issue":"1589","key":"10.1016\/j.heliyon.2019.e02890_bib7","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1098\/rspb.2005.3413","article-title":"Parasites as causative agents of human affective disorders? The impact of anti-psychotic, mood-stabilizer and anti-parasite medication on Toxoplasma gondii\u2019s ability to alter host behaviour","volume":"273","author":"Webster","year":"2006","journal-title":"Proc. R. Soc. Biol. Sci."},{"issue":"3","key":"10.1016\/j.heliyon.2019.e02890_bib8","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1093\/schbul\/sbm008","article-title":"Effects of Toxoplasma gondii infection on the brain","volume":"33","author":"Carruthers","year":"2007","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.heliyon.2019.e02890_bib9","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/nrn1220","article-title":"Neurobiology of suicidal behaviour","volume":"4","author":"Mann","year":"2003","journal-title":"Nat. Rev. Neurosci."},{"issue":"2","key":"10.1016\/j.heliyon.2019.e02890_bib10","doi-asserted-by":"crossref","first-page":"95","DOI":"10.14411\/fp.2010.012","article-title":"Toxoplasma gondii-altered host behaviour: clues as to mechanism of action","volume":"57","author":"Webster","year":"2010","journal-title":"Folia Parasitol."},{"issue":"4","key":"10.1016\/j.heliyon.2019.e02890_bib11","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0091-3057(01)00746-8","article-title":"Molecular, pharmacological and functional diversity of 5-HT receptors","volume":"71","author":"Hoyer","year":"2002","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"1","key":"10.1016\/j.heliyon.2019.e02890_bib12","article-title":"Evidence for the existence of monoamine-containg neurons in the central nervous system I. Demostrationof monoamines in the cellbodies of brain stem neurons","volume":"18","author":"Dahlstr\u00f6m","year":"1964","journal-title":"Acta Physiol. Scand. Suppl."},{"key":"10.1016\/j.heliyon.2019.e02890_bib13","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.neuroscience.2014.03.049","article-title":"Astrocytes, microglia\/macrophages, and neurons expressing Toll-like receptor 11 contribute to innate immunity against encephalitic Toxoplasma gondii infection","volume":"269","author":"Atmaca","year":"2014","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.heliyon.2019.e02890_bib14","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.exppara.2009.05.011","article-title":"Toxoplasma gondii: the role of IFN-gamma, TNFRp55 and iNOS in inflammatory changes during infection","volume":"123","author":"Silva","year":"2009","journal-title":"Exp. Parasitol."},{"issue":"4","key":"10.1016\/j.heliyon.2019.e02890_bib15","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2-\u0394\u0394CT method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"issue":"5","key":"10.1016\/j.heliyon.2019.e02890_bib16","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.mehy.2009.04.013","article-title":"Psychosis may be associated with toxoplasmosis","volume":"73","author":"Zhu","year":"2009","journal-title":"Med. Hypotheses"},{"issue":"1","key":"10.1016\/j.heliyon.2019.e02890_bib17","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1006\/brbi.2000.0613","article-title":"Cytokine-induced sickness behavior: where do we stand?","volume":"15","author":"Dantzer","year":"2001","journal-title":"Brain Behav. Immun."},{"issue":"5","key":"10.1016\/j.heliyon.2019.e02890_bib18","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0924-9338(01)00585-5","article-title":"Differences in interleukins\u2019 patterns between dysthymia and major depression","volume":"16","author":"Schlatter","year":"2001","journal-title":"Eur. Psychiatry"},{"issue":"1","key":"10.1016\/j.heliyon.2019.e02890_bib19","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1017\/S003329170500632X","article-title":"Cutaneous glucocorticoid receptor sensitivity and pro-inflammatory cytokine levels in antidepressant-resistant depression","volume":"36","author":"Fitzgerald","year":"2006","journal-title":"Psychol. Med."},{"issue":"2","key":"10.1016\/j.heliyon.2019.e02890_bib20","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.bbi.2005.05.004","article-title":"Dissociation of inflammatory markers and natural killer cell activity in major depressive disorder","volume":"20","author":"Pike","year":"2006","journal-title":"Brain Behav. Immun."},{"issue":"1","key":"10.1016\/j.heliyon.2019.e02890_bib21","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0165-1781(93)90027-E","article-title":"Relationships between interleukin-6 activity, acute phase proteins, and function of the hypothalamic-pituitary-adrenal axis in severe depression","volume":"49","author":"Maes","year":"1993","journal-title":"Psychiatry Res."},{"issue":"2","key":"10.1016\/j.heliyon.2019.e02890_bib22","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/BF00933779","article-title":"Effect of the strain of Toxoplasma gondii on the development of toxoplasmic encephalitis in mice treated with antibody to interferon-gamma","volume":"80","author":"Suzuki","year":"1994","journal-title":"Parasitol. Res."},{"issue":"3","key":"10.1016\/j.heliyon.2019.e02890_bib23","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0920-9964(02)00357-2","article-title":"Drugs used in the treatment of schizophrenia and bipolar disorder inhibit the replication of Toxoplasma gondii","volume":"62","author":"Jones-Brando","year":"2003","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.heliyon.2019.e02890_bib24","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1002\/eji.1830220921","article-title":"Kinetics of cytokine mRNA production in the brains of mice with progressive toxoplasmic encephalitis","volume":"22","author":"Hunter","year":"1992","journal-title":"Eur. J. Immunol."},{"issue":"2","key":"10.1016\/j.heliyon.2019.e02890_bib25","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/00034983.1985.11811902","article-title":"Changes in brain concentrations of catecholamines and indoleamines in Toxoplasma gondii infected mice","volume":"79","author":"Stibbs","year":"1985","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"10.1016\/j.heliyon.2019.e02890_bib26","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.neuropharm.2014.11.016","article-title":"Activation of 5-HT2a receptors in the basolateral amygdala promotes defeat-induced anxiety and the acquisition of conditioned defeat in Syrian hamsters","volume":"90","author":"Clinard","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.heliyon.2019.e02890_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2007.01.056","article-title":"Hypothalamic expression of serotonin 1A, 2A and 2C receptor and GAD67 mRNA in female cynomolgus monkeys with different sensitivity to stress","volume":"1142","author":"Centeno","year":"2007","journal-title":"Brain Res."},{"issue":"5","key":"10.1016\/j.heliyon.2019.e02890_bib28","doi-asserted-by":"crossref","first-page":"578","DOI":"10.2174\/1389450111314050007","article-title":"Serotonergic drugs for depression and beyond","volume":"14","author":"Stahl","year":"2013","journal-title":"Curr. Drug Targets"},{"issue":"3","key":"10.1016\/j.heliyon.2019.e02890_bib29","doi-asserted-by":"crossref","DOI":"10.1007\/s12017-009-8105-y","article-title":"HTR2A is associated with SSRI response in major depressive disorder in a Japanese Cohort","volume":"12","author":"Kishi","year":"2010","journal-title":"NeuroMolecular Med."},{"key":"10.1016\/j.heliyon.2019.e02890_bib30","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/1099-1077(200008)15:6<397::AID-HUP212>3.0.CO;2-L","article-title":"A\u00a0review of the role of serotonin receptors in psychiatric disorders","volume":"15","author":"Naughton","year":"2000","journal-title":"Hum. Psychopharmacol. Clin. Exp."},{"issue":"7","key":"10.1016\/j.heliyon.2019.e02890_bib31","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.neubiorev.2008.03.006","article-title":"Genetic variation in cortico-amygdala serotonin function and risk for stress-related disease","volume":"32","author":"Holmes","year":"2008","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"7","key":"10.1016\/j.heliyon.2019.e02890_bib32","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/cns.12247","article-title":"Interplay between serotonin 5-HT1A and 5-HT7 receptors in depressive disorders","volume":"20","author":"Naumenko","year":"2014","journal-title":"CNS Neurosci. Ther."},{"issue":"1","key":"10.1016\/j.heliyon.2019.e02890_bib33","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.neuropharm.2005.01.025","article-title":"Serotonin 5-HT7 receptors coupled to induction of interleukin-6 in human microglial MC-3 cells","volume":"49","author":"Mah\u00e9","year":"2005","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.heliyon.2019.e02890_bib34","first-page":"39","article-title":"5HT1A receptors and pharmacotherapy. Is serotonin receptor down-regulation linked to the mechanism of action of antidepressant drugs?","volume":"30","author":"Stahl","year":"1994","journal-title":"Psychopharmacol. Bull."},{"issue":"4","key":"10.1016\/j.heliyon.2019.e02890_bib35","first-page":"385","article-title":"[Mechanism of action of antidepressants and therapeutic perspectives]","volume":"57","author":"Bourin","year":"2002","journal-title":"Therapie"},{"key":"10.1016\/j.heliyon.2019.e02890_bib36","doi-asserted-by":"crossref","first-page":"448","DOI":"10.3389\/fnins.2014.00448","article-title":"The 5-HT7 receptor as a potential target for treating drug and alcohol abuse","volume":"8","author":"Hauser","year":"2015","journal-title":"Front. Neurosci."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844019365491?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844019365491?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,2]],"date-time":"2025-02-02T09:02:55Z","timestamp":1738486975000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844019365491"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":36,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S2405844019365491"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2019.e02890","relation":{},"ISSN":["2405-8440"],"issn-type":[{"type":"print","value":"2405-8440"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expression of serotonin 2A, 2C, 6 and 7 receptor and IL-6 mRNA in experimental toxoplasmic encephalitis in mice","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2019.e02890","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Author. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e02890"}}